Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) FCF Margin (2025)

Historic FCF Margin for Coeptis Therapeutics Holdings (COEP) over the last 1 years, with Q3 2025 value amounting to 906.42%.

  • Coeptis Therapeutics Holdings' FCF Margin changed N/A to 906.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 1667.01%, marking a year-over-year change of. This contributed to the annual value of 8319.25% for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' FCF Margin is 906.42%.
  • Coeptis Therapeutics Holdings' FCF Margin's 5-year high stood at 906.42% during Q3 2025, with a 5-year trough of 3763.35% in Q1 2025.